For instance, loss or reduced PHLPP1 promotes proliferative pathways and is frequently associated with cancer, whereas gain of PHLPP1 results in termination of metabolic signaling pathways and neuronal cell survival pathways, which are often associated with insulin resistance in diabetes (22) and neurological disorders, respectively (23). Here, PHLPP1 is linked to cancer.